Podcast As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon May 27, 2026
Podcast The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue May 20, 2026
Cancer History ProjectFreePodcast “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research HospitalIn a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process May 15, 2026Vol.52 No.19By Claire Marie Porter
Podcast Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now) May 13, 2026
Podcast Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time May 06, 2026
PodcastThe Directors The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open“There’s a tightening of the belt, and when the belt gets tightened, it has downstream effects.” April 24, 2026Vol.52 No.16By Claire Marie Porter and Paul Goldberg
Podcast NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown April 15, 2026
Podcast HHS Secretary Kennedy’s diet advice is heavy on meat and light on scientific consensus April 08, 2026